Key Metrics: Illumina, CleanSpark, MaxCyte, and Proterra's Earnings Preview
- August 06th, 2023
- 378 views
A lineup of companies is poised to reveal their financial insights on Wednesday, August 9, shedding light on their recent performances and market trends. These companies include:
Illumina, Inc. (Nasdaq: ILMN), a leader in genetic sequencing and analysis, is set to issue its second-quarter 2023 results following the closure of the market.
The consensus EPS estimate stands at $0.02 on revenue totaling $1.16 billion.
$ILMN closed at $187.67 on Friday, reflecting a gain of $2.33 (+1.26%).
CleanSpark Inc. (Nasdaq: CLSK), an innovative energy software company, will be reporting its fiscal third-quarter 2023 financial results after the close of regular trading.
Analysts are forecasting a loss of $0.17 per share on revenue amounting to $45.71 million.
On Friday, $CLSK closed at $5.30, down $0.20 (-3.64%).
MaxCyte, Inc. (Nasdaq: MXCT), a pioneer in cell-based therapies, is scheduled to release its financial results for the second quarter of 2023 after the U.S. market closes.
Analysts are expecting a loss of $0.10 per share on revenue totaling $10.8 million.
$MXCT closed at $4.33 on Friday, marking a decline of $0.07 (-1.59%).
Proterra Inc. (Nasdaq: PTRA), a leader in electric transportation solutions, will be reporting its second-quarter 2023 financial results following the close of the market.
The consensus estimate points to a loss of $0.26 per share on revenue of $93.33 million.
On Friday, $PTRA closed at $1.59, down $0.13 (-7.55%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026




Member Login